Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Endocrine 2Head & Neck 1CNS 1

Conditions

Thyroid cancer, medullary 1Pheochromocytoma 1Parathyroid Neoplasms 1Paraganglioma 1Neuroblastoma 1Multiple Endocrine Neoplasia 1Insulinoma 1Hypoglycemia 1Hyperparathyroidism 1Hypercalcemia 1Carcinoid Tumor 1

Interventions

Specimen Handling 2Radiotherapy 2Magnetic Resonance Spectroscopy 2tipifarnib 1pentetreotide 1lutetium Lu 177 dotatate 1gallium Ga 68 dotatate 1fostamatinib 1fluorodopa F 18 1fludarabine phosphate 1cabozantinib 1atezolizumab 1Tamoxifen 1Ritonavir 1Quality of Life 1Patient Reported Outcome Measures 1Octreotide 1Nivolumab 1Molecular Diagnostic Techniques 1Ipilimumab 1Interleukin-13 1Indinavir 1Immunotherapy 1Genetic Testing 1Fluorodeoxyglucose F18 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1Cryosurgery 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pheochromocytoma × fluorodopa F 18 × Head & Neck × Clear all
NCT02431715 2023-02-21

18F-FDOPA PET in Neuroendocrine Tumours

British Columbia Cancer Agency

No longer available
CNSEndocrineHead & Neck

Thyroid cancer, medullary, Carcinoid Tumor, Insulinoma, Neuroblastoma, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡